Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids

Cell Growth and Differentiation

Volumn 10, Issue 8, 1999, Pages 591-600

  Kang, Jing X ^a,b   Bell, Jennifer ^a,b   Beard, Richard L ^c   Chandraratna, Roshantha A S ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; MANNOSE 6 PHOSPHATE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CELL SPREADING; CELL STRAIN COS1; CELL STRUCTURE; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; GROWTH INHIBITION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BINDING, COMPETITIVE; CELL DIVISION; CELL LINE; CYTOSKELETON; HEART; HUMANS; MACROPHAGES; MICE; MICROFILAMENTS; MYOCARDIUM; RATS; RECEPTOR, IGF TYPE 2; RECEPTORS, RETINOIC ACID; RETINOIDS; TRANSFECTION;

EID: 0032766413     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Kornfeld, S. Structure and function of the mannose 6-phosphate/ insulin-like growth factor II receptors. Annu. Rev. Biochem., 61: 307-330, 1992.
2. Dahms, N. M. Insulin-like growth factor II/cation-independent mannose 6-phosphate receptor and lysosomal enzyme recognition. Biochem. Soc. Trans. 24: 136-141, 1996.
3. Kiess, W., Hoeflich, A., Yang, Y., Kessler, U., Flyvbjerg, A., and Barenton, B. The Insulin-like growth factor II/mannose 6-phosphate receptor: structure, function and differential expression. In: D. LeRoith and M. K. Raizada (eds), Current Directions in Insulin-like Growth Factor Research, pp. 137-188. New York: Plenum Press, 1994.
4. Lau, M. M. H., Stewart, C. E. H., Liu, Z., Bhatt, H., Rotwein, P., and Stewart, C. L. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 8: 2953-2963, 1994.
5. Wang, Z., Fung, M. R., Barlow, D. P., and Wagner, E. F. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature (Lond.), 372: 2585-2588, 1994.
6. Ludwig, T., Eggenschwiler, J., Fisher, P., D'Ercole, A. J., Davenport, M. L., and Efstratiadis, A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev. Biol. 177: 517-535, 1996.
7. Sue, S. R., Chari, R. S., Kong, F. M., Mills, J. J., Fine, R. L., Jirtle, R. L., and Meyers, W. C. Transforming growth factor-β receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann. Surgery, 222: 171-178, 1995.
8. De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C., and Jirtle, R. L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet., 11: 447-449, 1995.
9. Hankins, G. R., De Souza, A. T., Bentley, R. C., Patel, M. R., Marks, J. R., Iglehart, J. D., and Jirtle, R. L. M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene, 12: 2003-2009, 1996.
10. Yamada, T., De Souza, A. T., Finkelstein, S., and Jirtle, R. L. Loss of the gene encoding mannose 6-phosphate/insuline-like growth factor II receptor is an early event in liver carcinogenesis. Proc. Natl. Acad. Sci. USA, 94: 10351-10355, 1997.
11. Wang, S., Souza, R. F., Kong, D., Yin, J., Smolinski, K. N., Zou, T. T., Frank, T., Young, J., Flanders, K. C., Sugimura, H., Abraham, J. M., and Meltzer, S. T. Deficient TGF-β1 activation and excessive IGF-II expression in IGF-II receptor-mutant tumors. Cancer Res., 57: 2543-2546, 1997.
12. Ouyang, H., Shiwaku, H. O., Hagiwara, H., Miura, K., Abe, T., Kato, Y., Ohtani, H., Shiiba, K., Souza, R. F., Meltzer, S. J., and Horii, A. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach and colorectum. Cancer Research, 57: 1851-1854, 1997.
13. Xu, Y. Q., Grundy, P., and Polychronakos, C. Aberrant imprinting of the insulin-like growth factor II gene in Wilms' tumor. Oncogene, 14: 1041-1046, 1997.
14. Chappell, S. A., Walsh, T., Walker, R. A., and Shaw J. A. Loss of heterozygosity at the mannose 6-phosphate/insulin-line growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas. Br. J. Cancer, 76: 1558-1551, 1997.
15. Piao, Z., Choi, Y., Park, C., Lee, W. J., Park, J. H., and Kim, H. Deletion of the M6P/IGF2R gene in primary hepatocellular carcinoma. Cancer Lett., 120: 39-43, 1997.
16. Mills, J. J., Fall, J. G., De Souza, A. T., and Jirtle, R. L. Imprinted M6P/IGF2R receptor is mutated in rat liver tumors. Oncogene, 16: 2797-2802, 1998.
17. De Luca, M. L. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 5: 2924-2933, 1991.
18. Sporn, M. B., Roberts, A. B., Goodman, D. S. (eds) The Retinoids: Biology, Chemistry and Medicine, Ed. 2. New York: Raven Press, 1994.
19. Alles, A. J., and Sulik, K. K. Retinoic acid-induced spina bifida: evidence for a pathogenic mechanism. Development (Camb.), 108: 73-81, 1990.
20. Ahuja, H. S., James, W., and Zakeri, Z. Rescue of the limb deformity in hammertoe mutant mice by retinoic acid-induced cell death. Dev. Dyn. 208: 466-481, 1997.
21. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 11: 493-504, 1995.
22. O'Connell, J. M., Chua, R., Hoyos, B., Buck, J., Chen, Y., Derguini, F., and Hammerling, U. Retro-retinoids in regulated cell growth and death. J. Exp. Med., 184: 549-555, 1996.
23. Sun, S. Y., Yue, P., Dawson, M. I., Shroot, B., Michel, S., Lamph, W. W., Heyman, R. A., Teng, M., Chandraratna, R. A. S., Shudo, K., Hong, W. K., and Lotan, R. Differntial effects of synthetic nuclar retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res., 57: 4931-4939, 1997.
24. Toma, S., Insnardi, L., Raffo, P., Riccardi, L., Dastoli, D., Apfel, C., LeMotte, P., and Bollag, W. RARα antagonist Ro 41-5253 inhibits proliferation and induces apotosis in breast-cancer cell lines. Int. J. Cancer, 78: 86-94, 1998.
25. Mologni, L., Ponzanelli, I., Bresciani, F., Saidiello, G., Bergamaschi, D., Gianni, M., Reichert, U., Rambaldi, A., Terao, M., and Garattini, E. The novel synthetic retinod 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood, 93: 1045-1061, 1999.
26. Clifford, J. L., Menter, D. G., Wang, M., Loten, R., and Lippman, S. M. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res. 59: 14-18, 1999.
27. Kim, Y. H., Dohi, D. F., Han, G. R., Zou, C. P., Oridate, N., Walsh, G. L., Nesbitt, J. C., Xu, X. C., Hong, W. K., Lotan, R., and Kurie, J. M. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res., 55: 5603-5610, 1995.
28. Kang, J. X., Li, Y., Leaf, A. Mannose 6-phosphate/insulin-like growth factor-II receptor is a novel receptor for retinoic acid. Proc. Natl. Acad. Sci. USA, 94: 13671-13676, 1997.
29. Kang, J. X., Bell, J., Leaf, A., Beard, R. L., Chandraratna, R. A. S. Retinoic acid alters intracellular trafficking of the mannose 6-phosphate/ insulin-line growth factor-II receptor and lysosomal enzymes. Proc. Natl. Acad. Sci. USA, 95: 13687-13691, 1998.
30. Gabel, C. A., Goldberg, D. E., and Kornfeld, S. Identification and characterization of cells deficient in the mannose 6-phosphate receptor: evidence for an alternate pathway for lysosomal enzyme tageting. Proc. Natl. Acad. Sci. USA, 80: 775-779, 1983.
31. Kyle, J. W., Nolan, C. M., Oshima, A., and Sly, W. S. Expression of human cation-independent mannose 6-phosphate receptor cDNA in receptor-negative mouse P388D1 cells following gene transfer. J. Biol. Chem. 263: 16230-16235, 1988.
32. Mangerlsdorf, D. J., Ong, E. S., Dyck, J. A., and Evans, R. M. Nuclear receptor that identifies a novel retinoc acid response pathway. Nature (Lond.), 345: 224-229, 1990.
33. Beard, R. L., Chandraratna, R. A. S., Colon, D. F., Gillett, S. J., Henry, E., Marler, D. K., Song, T., Denys, L., Garst, M. E., Arefie, G. T., Klein, E., Gil, D. W., Wheeler, L., Kochhar, D. M., and Davies, P. J. A. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids. J. Med. Chem. 38: 2820-2829, 1995, 1995.
34. Boehm, M. F., McClurg, M., Pathirana, C., Mangelsdorf, D., White, S. K., Hebert, J., Winn, D., Goldman, M., and Heyman, R. A. Synthesis of a high specific activity [3H]-9-cis retinoic acid and its application for identifying retinoids with unusual binding properties. J. Med. Chem., 37: 408-414, 1994.
35. Johnson, A. T., Klein, E. S., Gillett, S. J., Wang, L., Song, T. K., Pino, M. E., and Chandraratna, R. A. S. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem,. 38: 4764-4767, 1995.
36. Agarwal, C., Chandraratna, R. A. S., Johnson, A. T., Rorke, E. A., and Eckert, R. L. AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells. J. Biol. Chem., 271: 12209-12212, 1996.
37. Klein, E. S., Pino, M. E., Johnson, A. T., Davies, P. J. A., Nagpal, S., Thacher, S. M., Krasinski, G., and Chandraratna, R. A. S. Identification and functional seperation of retinoic acid receptor neutral antagonists and inverse agonists. J. Biol. Chem., 271: 22692-22696, 1996.
38. Robertson, K. A., Ernami, B., and Collins, S. J. Retinoic acid-resistant HL-60R cells harbor a ponit mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood, 80: 1885-1889, 1992.
39. Nagy, L., Thomazy, V. A., Shipley, G. L., Fesus, L., Lamph, W., Heyman, R. A., Chandraratna, R. A. S., and Davies, P. J. A. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol., 15: 3540-3551, 1995.
40. Atkins, K. B., Troen, B. R. Comparative responsiveness of HL-60, HL-60R and HL-60+ cell to retinoic acid, Calcitriol, 9 cis-retinoic acid and sodium butyrate. Blood, 86: 2475-2480, 1995.
41. Jirtle, R. L., Haag, J. D., Ariazi, E. A., and Gould, M. N. Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor β1 levels during monoterpene-induced regression of mammary tumors. Cancer Res. 53: 3849-3852, 1993.
42. Mills, J. J., Chari, R. S., Boyer, I. J., Gould, M. N., and Jirtle, R. L. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res. 55: 979-983, 1995.
43. Nissley, P., Kiess, W., and Skler, M. Developmental expression of the IGF-II/Mannose 6-phosphate receptor. Mol. Reprod. Dev., 35: 408-413, 1993.
44. Dennis, P. A., and Rifkin, D. B. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA, 88: 580-584, 1991.
45. Blanchard, F., Raher, S., Duplomb, L., Vusio, P., Pitard, V., Taupin, J. L., Moreau, J. F., Hoflack, B., Minvielle, S., Jacques, Y., and Godard, A. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor. J. Biol. Chem., 273: 20886-20893, 1998.
46. Cacia, J., Quan, C. P., Pai, R., and Frenz, J. Human Dnase I contains mannose 6-phosphate and binds the cation-independent mannose 6-phosphate receptor. Biochemistry. 37: 15154-15161, 1998.
47. Capony, F., Rougeot, C., Montcourrier, P., Cavailles, V., Salazar, G., and Rochefort, H. Increased secretion, altered processing and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res. 49: 3904-3909, 1989.
48. Gacko, M., Bankowska, A., Chyczewska, E., and Worowska, A. Lysosomal cysteine proteinases and their significance in pathology. Rocz. Akad. Med. Bialymstoku., 42 (Suppl. 1): 60-71, 1997.
49. Brouillet, J. P., Dufour, F., Lemamy, G., Garcia, M., Schlup, N., grenier, J., Mani, J. C., and Rochefort, H. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay. Cancer (Phila.), 79: 2132-2136, 1997.
50. Deiss, L. P., Galinka, H., Berissi, H., Cohen, O., and Kimchi, A. Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNF-α. EMBO J., 75: 3861-3870, 1996.
51. Narvaez, C. J., Vanweelden, K., Byrne, I., and Welsh, J. Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology, 137: 400-409, 1996.
52. Moallem, S. A., and Hales, B. F. Induction of apoptosis and cathepsin D in limbs exposed in vitro to an activated analog of cyclophosphamide. Teratology, 52, 3-14, 1995.
53. Glick, A. B., Flanders, K. C., Danielpour, D., Yuspa, S. H., and Sporn, M. B. Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul., 1:87-97, 1989.
54. Degitz, S. J., Morris, D., Foley, G. L., and Francis, B. M. Role of TGF-β in RA-induced cleft palate in CD-1 mice. Teratology, 58: 197-204, 1998.
55. Nugent, P., Ma, L., and Greene, R. M. Differential expression and biological activity of retinoic acid-induced TGF-β isoforms in embryonic palate mesenchymal cells. J. Cell. Physiol., 177: 36-46, 1998.
56. Melnick, M., Chen, H., Buckley, S., Warburton, D., and Jaskoll, T. Insulin-like growth factor II receptor, transforming growth factor-β, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis. Dev. Dyn., 211: 11-25, 1998.
57. Abu-Hijleh, G., and Padmanabhan, R. Retinoic acid-induced abnormal development of hindlimb joints in the mouse. Eur. J. Morphol. 35: 327-336, 1997.
58. Minniti, C. P., Kohn, E. C., Grubb, J. H., Sly, W. S., Oh, Y., Muller H. L., Rosenfeld, R. G., and Helman, L. J. The insulin-line growth factor II/ mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J. Biol. Chem., 267: 9000-9004, 1992.